MedTrace Logo

Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment

NCT01145144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2010-06-16

No results posted yet for this study

Summary

The aim of this study was to evaluate the effect of dehydroepiandrosterone supplementation on in vitro fertilization performance and outcome among poor-responder patient.

Conditions

  • Ovarian Stimulation

Interventions

DRUG

dehydroepiandrosterone crystalline fine powder

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01145144 on ClinicalTrials.gov